Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Eliminates 315 Jobs, Records $18.2M in Charges

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific took charges of $18.2 million during the first quarter associated with a reduction in headcount of about 315 employees, the company said in its Form 10-Q this week.

The charges are cash costs related to headcount reductions and facility consolidations and consisted of severance to the employees who were laid off. It is unclear whether all 315 layoffs occurred in the first quarter ended March 31, however.

The company took $7.9 million in cash costs in its Analytical Technologies segment related to the layoffs of about 170 employees, it said in its document filed with the US Securities and Exchange Commission.

In Specialty Diagnostics, cash costs amounted to $6.5 million in severance for approximately 75 employees, and in Laboratory Products and Services, Thermo Fisher recorded cash costs of $3.8 million in severance for about 70 employees.

In 2012, the company eliminated about 1,120 jobs. Thermo Fisher currently plans to buy Life Technologies for about $13.6 billion.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.